欢迎您, 登录 | 注册

首页 | English

X
加载中

Enteric pathogenic bacteria such as Vibrio cholerae and enteropathogenic Escherichia coli (E. coli) cause life-threatening diarrheal diseases that have afflicted humans for centuries. Understanding the effectors required for intestinal colonization is very important to research on bacteria pathogenesis, and is also important to testing new therapeutics and development of the novel vaccines. Here, we describe the Infant Rabbit Colonization Competition Assay, a variant method of the powerful, nonsurgical animal model reported by Ritchie et al. (2010). In our modified assay, wild type and mutant strains are mixed together and inoculated into 2-day-old New Zealand white rabbits. The competitive index for each mutant measures the colonization capacity of the mutant relative to its wild type parental strain in the gastrointestinal tract. Compared to the traditional Sucking Mice model, the clinical and histologic signs of Vibrio cholerae (V. cholerae)-induced disease of infant rabbits more closely resemble human cholera. The larger input bacteria amount of this model also facilitates high-throughput screens, such as Tn-Seq technology (Fu et al., 2013).

Thanks for your further question/comment. It has been sent to the author(s) of this protocol. You will receive a notification once your question/comment is addressed again by the author(s).
Meanwhile, it would be great if you could help us to spread the word about Bio-protocol.

X

Infant Rabbit Colonization Competition Assays
幼兔肠道中不同菌株的定植竞争分析

微生物学 > 微生物-宿主相互作用 > 体内实验模型 > 哺乳动物
作者: Yang Fu
Yang FuAffiliation: Department of Microbiology and Immunobiology, Harvard Medical School, Boston, USA
For correspondence: yang_fu@hms.harvard.edu
Bio-protocol author page: a1395
 and John J. Mekalanos
John J. MekalanosAffiliation: Department of Microbiology and Immunobiology, Harvard Medical School, Boston, USA
For correspondence: john_mekalanos@hms.harvard.edu
Bio-protocol author page: a1396
Vol 4, Iss 11, 6/5/2014, 2190 views, 0 Q&A, How to cite
DOI: http://dx.doi.org/10.21769/BioProtoc.1147

[Abstract] Enteric pathogenic bacteria such as Vibrio cholerae and enteropathogenic Escherichia coli (E. coli) cause life-threatening diarrheal diseases that have afflicted humans for centuries. Understanding the effectors required for intestinal colonization is very important to research on bacteria pathogenesis, and is also important to testing new therapeutics and development of the novel vaccines. Here, we describe the Infant Rabbit Colonization Competition Assay, a variant method of the powerful, nonsurgical animal model reported by Ritchie et al. (2010). In our modified assay, wild type and mutant strains are mixed together and inoculated into 2-day-old New Zealand white rabbits. The competitive index for each mutant measures the colonization capacity of the mutant relative to its wild type parental strain in the gastrointestinal tract. Compared to the traditional Sucking Mice model, the clinical and histologic signs of Vibrio cholerae (V. cholerae)-induced disease of infant rabbits more closely resemble human cholera. The larger input bacteria amount of this model also facilitates high-throughput screens, such as Tn-Seq technology (Fu et al., 2013).

Keywords: Vibrio Cholerae(霍乱弧菌), Enteric Bacteria(肠道细菌), Animal Model(动物模型), Colonization Factor(定植因子), Competetion Assay(竞争分析)

Materials and Reagents

  1. New Zealand white infant rabbit (2-5 days old) (Millbrook farm)
  2. Lactating doe (Millbrook farm)
  3. Vibrio cholerae
    Note: Alternatively, any enteric pathogenic bacteria that can successfully colonize the infant rabbit gut system can be used in this protocol.
  4. Zantac (GlaxoSmithKline, NDC: 0173-0363-01)
  5. 40 mEq/20 ml potassium chloride (KCl) (Hospira, NDC: 0409-6653-05)
  6. Isoflurane (USP) (Piramal Enterprises, NDC: 66794-013-25)
  7. Phosphate buffered saline (PBS) (Lonza, catalog number: 51225)
  8. X-gal and/or antibiotics (depend on the selective marker of the experimental strain)
  9. 70% ethanol
  10. 2.5% sodium bicarbonate buffer (pH 8.0) (see Recipes)
  11. Luria-Bertani broth (LB) medium and LB agar solid medium (see Recipes)

Equipment

  1. BL2 animal facility
  2. Fume hood
  3. 37 °C incubator or warm room
  4. 1 ml sterile syringe (BD, catalog number: 305553)
  5. 3 ml sterile syringe (BD, catalog number: DG508504)
  6. 26 G 5/8 needle (BD, catalog number: 305115)
  7. Surgical scissors and tweezers (Fine Science Tools)
  8. Centrifuge (Eppendorf, model: 5424)
  9. 1.5 ml sterile microcentrifuge tube
  10. 96 wells tissue culture plate (BD, catalog number: 353072)
  11. Size 5 French catheter
  12. Silk ligature
  13. Shaker
  14. Spectrophotometer
  15. Mini-bead beater-16 (Bio Spec Products, catalog number: 607)

Procedure

  1. Check the litters on the day when they arrive: Litters of 2-5 day old New Zealand white rabbits and the lactating doe are obtained from a commercial vendor and housed together for the duration of the experiments. A minimum of six rabbits need to be assayed for each strain to be evaluated.
  2. Inocula preparation: A single colony from a freshly streaked plate of each mutant (lacZ+) and wild type (lacZ-) is grown in LB containing the selective antibiotic of the experimental strains for approximate 5 to 6 h at 37 °C with shaking. The bacterial cells are pelleted (9,000 rpm for 5 min), the supernatant is discarded and the pellet is resuspended in sterile sodium bicarbonate buffer. The concentration of bacteria is adjusted to about 2 x 109 cfu/ml. Wild type and mutant solutions are then mixed together (1:1).
  3. Zantac treatment (3 h prior to inoculation): Infant rabbits are weighed and administered Zantac by intraperitoneal (i.p) injection (2 mg per kg body weight) using a 26 G needle and 1 ml syringe. (This dose of anti-acid treatment has been found to transiently alter the pH of the stomach without causing ill-effects in the infant rabbits.).  
  4. 3 h post-Zantac treatment: Infant rabbits are oro-gastrically inoculated with 0.5 ml of bacteria using a size 5 French catheter with flexible tip. The suggested dose is 1 x 109 cfu/ml per 90 g of rabbit body weight.
  5. Input ratio determination: Inocula are serial diluted in 1x PBS and plated on LB agar containing X-gal. CFU of white and blue colonies are counted after overnight incubation at 37 °C.
  6. Clean the catheter: Wash the catheter with 70% ethanol, H2O and 1x PBS sequentially.
  7. Monitor rabbits: Infant rabbits are monitored for diarrhea and signs of illness (e.g. dehydration, low body temperature, scruffy fur, lethargy and decreased muscle tone) and routinely euthanized within few days.
  8. Euthanasia: Infant rabbits are anesthetized by inhalation of isoflurane and euthanized by intracardiac injection of KCl (2 mEq/ml, 3 ml).
  9. Necropsy: The entire intestinal tract from the duodenum to the rectum is removed.
    1. Cecal fluid: Cecal fluid (1-2 ml per rabbit) is collected by first isolating the cecum from the rest of the intestine with silk ligatures; then, the cecal contents are collected by snipping the end of the cecum and allowing the contents to drain under gravity into a collection tube. 1 ml cecal fluid of each rabbit is used for the CFU counting.
    2. Distal small intestine and colon: A 1 cm sample is cut and removed, and then homogenized (e.g. bead beater or slides scissoring) in 1 ml of 1x PBS.
  10. Output ratio determination: Serial dilutions of each sample are plated in LB solid media with antibiotic and X-gal and incubated overnight at 37 °C to enumerate the output ratio of the wild type and mutant strain.
  11. Competitive Index (C.I) counting: The competitive index for each mutant is defined as the input ratio of mutant/WT strain divided by the output ratio of mutant/WT strain. (Figure 1)

Representative data

  1. Example of infant rabbit competitive index counting


    Figure 1. Infant rabbit competition assays of intestinal colonization related mutants of Vibrio cholerae C6706 strain. In vivo competition experiments were performed comparing the colonization related mutants to parental strain C6706 lacZ- (WT). Left, negative control mutant C6706 lacZ+; Middle left, severe colonization defective mutantΔtcpA; Middle right, intermediate defect mutant ΔdncV and Right, hyper-colonization mutant ΔvspR. Statistical significance was determined by t test relative to the C.I. determined for a competition between C6706 lacZ+ versus WT with **** indicating a P value < 0.0001, *** P< 0.001. Mean with SEM was shown.

Notes

  1. Ethics statement
    All animal experiments were performed with protocols approved by the Harvard Medical School Office for Research Protection Standing Committee on Animals in accordance to NIH guidelines. The Harvard Medical School animal management program is also accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC International). The institution also accepts as mandatory the PHS Policy on Humane Care and Use of Laboratory Animals by Awardee Institutions and NIH Principles for the Utilization and Care of Vertebrate Animals Used in Testing, Research, and Training. The office of Laboratory Animal Welfare (OLAW) has the approved Assurance of Compliance (A3431-01) on file.

Recipes

  1. 2.5% sodium bicarbonate buffer (pH 8.0) (100 ml)
    Mix 2.5 g Sodium Bicarbonate with 80 ml dH2O
    pH to 8.0 with NaOH
    Add dH2O to 100 ml
    Filter sterilize (0.2 μm)
    Stored at room temperature
  2. Luria-Bertani broth (LB) medium (1 L)
    Mix of 10 g tryptone, 10 g NaCl and 5 g yeast extract
    Add dH2O to 1 L
    For LB agar add agar to a final concentration of 1.5%
    Heat the mixture to boiling to dissolve agar and sterilize by autoclaving at 15 psi, from 121-124 °C for 15 min
    Stored at room temperature

Acknowledgments

This protocol was first described and used in our previous Vibrio cholerae intestinal colonization study (Fu et al., 2013), and was adapted from a precious infant rabbit model, which was described by Ritchie et al. (2010). We thank Dr. Waldor and Dr. Ritchie for helpful suggestions and comments. This work was funded by grants AI-018045 and AI-26289 to J.J.M. from the National Institute of Allergy and Infectious Disease.

References

  1. Fu, Y., Waldor, M. K. and Mekalanos, J. J. (2013). Tn-Seq analysis of Vibrio cholerae intestinal colonization reveals a role for T6SS-mediated antibacterial activity in the host. Cell Host Microbe 14(6): 652-663.
  2. Ritchie, J. M., Rui, H., Bronson, R. T. and Waldor, M. K. (2010). Back to the future: studying cholera pathogenesis using infant rabbits. MBio 1(1).


How to cite this protocol: Fu, Y. and Mekalanos, J. J. (2014). Infant Rabbit Colonization Competition Assays. Bio-protocol 4(11): e1147. DOI: 10.21769/BioProtoc.1147; Full Text



可重复性反馈:

  • 添加图片
  • 添加视频

我们的目标是让重复别人的实验变得更轻松,如果您已经使用过本实验方案,欢迎您做出评价。我们鼓励上传实验图片或视频与小伙伴们(同行)分享您的实验心得和经验。(评论前请登录)

问题&解答:

  • 添加图片
  • 添加视频

(提问前,请先登陆)bio-protocol作为媒介平台,会将您的问题转发给作者,并将作者的回复发送至您的邮箱(在bio-protocol注册时所用的邮箱)。为了作者与用户间沟通流畅(作者能准确理解您所遇到的问题并给与正确的建议),我们鼓励用户用图片或者视频的形式来说明遇到的问题。由于本平台用Youtube储存、播放视频,作者需要google 账户来上传视频。


登陆 | 注册
分享
Twitter Twitter
LinkedIn LinkedIn
Google+ Google+
Facebook Facebook